VaramirStart free · no cardSign in
EBS as of Oct 31 · 15:39 ET
EBSNYSEPharmaceutical Preparations

Emergent BioSolutions Inc. · Brief

Next report

9 days

Nov 9 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
6 of 8≥ implied
avg implied
±17.0%
avg realized
±24.1%
Nov 6 '24±14.7%▲+19.57%×1.33
Mar 3 '25±20.3%▼−6.44%×0.32
May 7 '25±9.8%▲+34.18%×3.48
Aug 6 '25±13.3%▲+36.65%×2.75
Oct 29 '25±23.1%▲+36.60%×1.58
Feb 26 '26±23.5%▼−26.58%×1.13
Q1 FY26±17.3%▲+2.92%×0.17
Q2 FY26±14.3%▼−29.58%×2.07
quarterimplied−40%0+40%realized×
Q2 FY26±14.3%▼−29.58%×2.07
Q1 FY26±17.3%▲+2.92%×0.17
Feb '26±23.5%▼−26.58%×1.13
Oct '25±23.1%▲+36.60%×1.58
Aug '25±13.3%▲+36.65%×2.75
May '25±9.8%▲+34.18%×3.48
2 older reports
Mar '25±20.3%▼−6.44%×0.32
Nov '24±14.7%▲+19.57%×1.33
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

14disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding EBSN-PORT · Aug 31 '26

Bear2

2 of 8recent reports that moved in under the options implied rangeEarnings history
6 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

EBS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±15.0% into Nov 9 earnings (Oct 28 close).Source
Oct 14impliedImplied move: ±20.6% into Oct 28 earnings (Oct 14 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.